跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Canesten® - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Canesten®
Approved
STANDARD
Canesten®
Haupt Pharma Wülfing GmbH Ex: Wülfing Pharma GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6ab4c2d35117b1a3
Company
Haupt Pharma Wülfing GmbH Ex: Wülfing Pharma GmbH
Type
Standard
Approval Details
Approval Id
6ab4c2d35117b1a3
Drug Approval Philippines Name
Canesten®
Product Name
Canesten®
Registration Number
DR-XY47795
Brand Name
Canesten®
Generic Name
Clotrimazole
Dosage Form
Vaginal Tablet
Dosage Strength
500mg
Manufacturer
Haupt Pharma Wülfing GmbH Ex: Wülfing Pharma GmbH
Importer
Bayer Philippines, Inc.
Distributor
Bayer Philippines, Inc.
Issuance Date
29 April 2022
Expiry Date
09 March 2027
Pharmacologic Category
Antifungal (Imidazole and Triazole derivative)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6ab4c2d35117b1a3
Type
Standard
Back to Philippines FDA Approvals